A previous study also demonstrated that H19/miR-193a-3p axis could modify the radio-resistance and chemotherapeutic tolerance of HCC cells by targeting Presenilin-1 (PSEN1), a core component of γ-secretase [85]. This evidence concerns the gene PSEN1 and hepatocellular carcinoma.